1Tabata M,Yoshida M,Izumi T,et al.Retrospective analysis of elderly patients 》 or=60 years of age with acute leukemia[J].Rinsho Ketsueki,1998,39(3):176-184.
2Bai A,Kojima H,Hori M,et al.Priming with G-CSF effectively enhances low-dose Ara-c-induced in vivo apoptosis in myeloid leukenia cells[J].Exp Hematol,1999,27(2):259-265.
3Saito K,Nakamura Y,Aoyagi M,et al.Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML:secondary AML and refractory anemia with excese blasts in transformation[J].Int J Hematol,2000,7(3):238-244.
